Trivector Cyclophilin Engagers as Immune-Oncology Adjuvants for Triple Negative Breast Cancer

Project Details

StatusActive
Effective start/end date1/06/2331/01/25

Funding

  • Medical Research Council: £6,000.00
  • Medical Research Council: £24,000.00